- Frouke M Engelaer, PhD student1,
- David van Bodegom, assistant professor of medicine at Leiden University Medical Centre1,
- Rudi G J Westendorp, professor of medicine at Leiden University Medical Centre1
- 1Leyden Academy on Vitality and Ageing, 2333 AA Leiden, Netherlands
- engelaer{at}leydenacademy.nl
The open label treatment extension of the original HYVET study received enthusiastic applause as further evidence for direct and long term benefits of treating hypertension in very old people (≥80 years).1 However, we should be cautious in extrapolating these findings to clinical practice.
It …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking